The group’s principle activity is to provide women's health pharmaceutical services. The group’s product includes low estrogen dose seven day transdermal contraceptive. The group operates from United States.
Executive Information
Name
Title
Email
Thomas Rossi
CEO, Pres.
N/A
Agis Kydonieus
Chief Scientific Officer
N/A
Marie Foegh
Chief Medical Officer, VP - Clinical Research, Development
